Table 1 The association of ZIP transporters with overall survival (OS) and progression-free survival (PFS) in ovarian cancer patients

ZIP1

1656

1.13 (0.97–1.33)

0.12

1435

1.16 (1.01–1.33)

0.037

ZIP2

1656

0.93 (0.80–1.07)

0.31

1435

0.89 (0.78–1.02)

0.089

ZIP3

655

1.18 (0.96–1.45)

0.11

614

0.86 (0.70–1.05)

0.14

ZIP4

1656

0.92 (0.80–1.05)

0.22

1435

0.92 (0.81–1.05)

0.2

ZIP5

655

1.32 (1.08–1.62)

0.0066

614

1.48 (1.23–1.79)

3.50E-05

ZIP6

1656

1.08 (0.94–1.25)

0.29

1435

0.84 (0.72–0.97)

0.019

ZIP7

1656

0.78 (0.67–0.90)

0.00058

1435

1.17 (1.03–1.33)

0.014

ZIP8

1656

1.06 (0.93–1.21)

0.37

1435

0.87 (0.75–1.01)

0.071

ZIP9

655

1.18 (0.94–1.48)

0.15

614

0.89 (0.74–1.08)

0.23

ZIP10

655

1.30 (1.06–1.60)

0.012

614

1.28 (1.06–1.55)

0.009

ZIP11

655

1.11 (0.90–1.38)

0.32

614

0.85 (0.70–1.04)

0.11

ZIP12

655

1.24 (1.01–1.54)

0.044

614

1.50 (1.22–1.84)

9.10E-05

ZIP13

655

1.66 (1.36–2.03)

7.50E-07

614

1.90 (1.58–2.30)

1.10E-11

ZIP14

1656

1.25 (1.10–1.42)

0.00066

1435

1.27 (1.12–1.44)

2.00E-04